In the Face of Complete Genomics' Competition, Global Financial Crisis, Genome Corp Closes Doors
January 20, 2009
In the Face of Complete Genomics' Competition, Global Financial Crisis, Genome Corp Closes Doors
Having raised $750,000 in startup funding, Genome Corp lost its prospective Series A lead investor last fall after Complete Genomics revealed a similar business model and faster commercialization plans.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Qiagen, BioBay Open Translational Medicine Center in China
May 24, 2013 / GenomeWeb Daily News - Study Suggests Genetic Susceptibility to T2D May Have Shifted with Human Migration
May 24, 2013 / GenomeWeb Daily News - Brazil Plans $680M for Research Institutes; Includes Genomics Center
May 23, 2013 / GenomeWeb Daily News - Beckman Coulter Genomics' BRAF Assay Receives State Licensures
May 23, 2013 / GenomeWeb Daily News - MIT Core Facility Develops Method to Breathe New Life into Unused Illumina GAII Sequencers
May 23, 2013 / In Sequence